CLINICAL TRIALS PROFILE FOR PROCARBAZINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for procarbazine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002462 ↗ | RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease | Active, not recruiting | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 | 1989-09-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with combination chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with no radiation therapy following chemotherapy in treating patients with stage III or stage IV Hodgkin's disease. |
| NCT00002463 ↗ | Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors | Completed | National Cancer Institute (NCI) | Phase 2 | 1989-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine, vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive neuroectodermal tumors. |
| NCT00002463 ↗ | Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors | Completed | M.D. Anderson Cancer Center | Phase 2 | 1989-02-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of methotrexate, mechlorethamine, vincristine, procarbazine, and prednisone in treating children with astrocytomas or primitive neuroectodermal tumors. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | National Cancer Institute (NCI) | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| NCT00002569 ↗ | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma | Completed | NCIC Clinical Trials Group | Phase 3 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without chemotherapy in treating patients who have anaplastic oligodendroglioma. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for procarbazine hydrochloride
Condition Name
Clinical Trial Locations for procarbazine hydrochloride
Trials by Country
Clinical Trial Progress for procarbazine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for procarbazine hydrochloride
Sponsor Name
| Sponsor Name for procarbazine hydrochloride | |
| Sponsor | Trials |
| National Cancer Institute (NCI) | 26 |
| European Organisation for Research and Treatment of Cancer - EORTC | 9 |
| Memorial Sloan Kettering Cancer Center | 5 |
| [disabled in preview] | 12 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
